Chemical Structure : E966-0530-45418
Catalog No.: PC-23770Not For Human Use, Lab Use Only.
E966-0530-45418 is a potent, selective inhibitor of CDK8 with IC50 of 129 nM, shows slightly weaker activity against CDK19 and does not inhibit other CDKs.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
E966-0530-45418 is a potent, selective inhibitor of CDK8 with IC50 of 129 nM, shows slightly weaker activity against CDK19 and does not inhibit other CDKs.
E966-0530-45418 significantly inhibits the phosphorylation of STAT1 at Ser727 in a concentration-dependent manner without affecting CDK8 expression in DU145 and PC-3 cells transfected with pcDNA3 CDK8-HA plasmid.
E966-0530-45418 significantly inhibits cell migration and the expression of EMT proteins in prostate cancer cells.
E966-0530-45418 suppresses TGF-β1/Smad signaling through inhibition of RNA polymerase II and Smad linker phosphorylation, inhibits β-catenin signaling and downstream proteins via CDK8 inhibition.
E966-0530-45418 (50 mg/kg, q.d., oral) exhibits antimetastatic properties in PC-3 SCID mouse model.
M.Wt | 496.51 | |
Formula | C24H21FN4O5S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Ho TY, et al. Biomed Pharmacother. 2023 Jun;162:114667.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright